...
首页> 外文期刊>PACE: Pacing and clinical electrophysiology >The World Survey of Cardiac Pacing and Implantable Cardioverter Defibrillators: calendar year 1997--Europe.
【24h】

The World Survey of Cardiac Pacing and Implantable Cardioverter Defibrillators: calendar year 1997--Europe.

机译:世界心脏起搏器和植入式心脏复律除颤器世界调查:1997日历年-欧洲。

获取原文
获取原文并翻译 | 示例

摘要

The registry of the European Working Group on Cardiac Pacing (EWGCP) is based on the European Pacemaker Identification Card originally designed in July 1978. National registration centers collect the local data and send aggregated annual data to the EWGCP. For 1997, data were obtained from 2,887 hospitals in 20 European countries representing a population of 568 million. Across all participating countries, the median value for all implanted pacemakers was 378 per million population. For initial pacemaker implants, the median value was 290 per million population. Single chamber atrial pacing was important in Denmark, the Netherlands, Poland, Slovak Republic, Spain, and Sweden for the treatment of sick sinus syndrome. Dual chamber pacing accounted for < 50% of initial implants in only 5 of 14 countries for atrioventricular block, and in only 3 of 15 countries for sick sinus syndrome. In 7 of 15 countries, unipolar ventricular leads were used in > or = 50% of cases. In 6 of 14 countries, there was > 15% use of unipolar atrial leads. Nine of 13 countries frequently used atrial active-fixation leads. For the 1997 survey, ICD data were obtained from 16 countries. The total number of ICDs per million population was a median value of 14. Initial ICD implants per million population was 11. Only 3 of 16 countries implanted a total of 30 or more ICDs per million population. Pacing and ICD practices were dependent on the availability of medical and technical resources and influenced by economic constraints inherent in health care administration and insurance coverage patterns.
机译:欧洲心脏起搏工作组(EWGCP)的注册表基于最初于1978年7月设计的欧洲起搏器身份证。国家注册中心收集本地数据,并将汇总的年度数据发送到EWGCP。 1997年的数据来自欧洲20个国家的2 887家医院,人口为5.68亿。在所有参与国中,所有植入式起搏器的中位数值为每百万人口378。对于最初的起搏器植入物,中位数值为每百万人口290。在丹麦,荷兰,波兰,斯洛伐克共和国,西班牙和瑞典,单室心房起搏对治疗鼻窦综合症很重要。在14个国家中只有5个国家的房室传导阻滞,双腔起搏占初始植入物的<50%,在15个国家中只有3个国家的病态窦房结综合征。在15个国家中的7个国家,≥50%的病例使用了单极心室导线。在14个国家中的6个国家中,单极心房导线的使用率超过15%。 13个国家中有9个经常使用心房活动固定导线。对于1997年的调查,ICD数据来自16个国家。每百万人口的ICD总数中位数为14。每百万人口中最初的ICD植入物为11。16个国家中只有3个国家每百万人口中总共植入了30个或更多ICD。起搏和ICD做法取决于医疗和技术资源的可用性,并受医疗保健管理和保险范围内在的固有经济限制的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号